CCR4-351 is an orally active, potent and selective CCR4 antagonist. CCR4-351, featuring a novel piperidinyl-azetidine motif, has IC50s of 22 nM and 50 nM in the calcium flux and CTX assay. CCR4-351 has antitumor activity[1].
Molecular Weight:
500.42
Purity:
98.02
CAS Number:
[2174938-70-4]
Formula:
C24H27Cl2N7O
Target:
CCR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted